Skip to main content

Conjunctival and Corneal Tumors: Melanoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

Abstract

Conjunctival nevi, conjunctival primary acquired melanosis (PAM), and conjunctival melanomas all arise from melanocytes that migrate from the neural crest to reside in the conjunctival epithelium. Conjunctival melanoma may arise de novo or from preexisting conjunctival nevus or PAM. In the medical literature, conjunctival melanoma is sometimes labeled together with uveal melanoma as “ocular melanoma.” The clinical behavior, molecular biology, and the histopathologic features of conjunctival and uveal melanoma are clearly different; therefore, conjunctival melanoma should be approached as an entity separate from uveal melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42(4):321–50.

    Article  PubMed  CAS  Google Scholar 

  2. Grossniklaus HE, Green WR, Luckenbach M, et al. Conjunctival lesions in adults. A clinical and histopathologic review. Cornea. 1987;6(12):78–116.

    Article  PubMed  CAS  Google Scholar 

  3. De Woolf-Rouendaal D. Conjunctival melanoma in the Netherlands: a clinico-pathological and follow-up study (thesis). Katwijk: All in BV; 1990.

    Google Scholar 

  4. Triay E, Bergman N, Nilsson B, et al. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol. 2009;93(11):1524–8.

    Article  PubMed  CAS  Google Scholar 

  5. Yu GP, Hu DN, McCormick S, et al. Conjunctival melanoma: Is it increasing in the United States? Am J Ophthalmol. 2003;135(6):800–6.

    Article  PubMed  Google Scholar 

  6. Isager P, Osterlind A, Engholm G, et al. Uveal and conjunctival malignant melanoma in Denmark, 1943–1997: incidence and validation study. Ophthalmic Epidemiol. 2005;12(4):223–32.

    Article  PubMed  CAS  Google Scholar 

  7. Taban M, Traboulsi EI. Malignant melanoma of the conjunctiva in children: a review of the international literature 1965-2006. J Pediatr Ophthalmol Strabismus. 2007;44(5):277–82.

    PubMed  Google Scholar 

  8. Benatiya Andaloussi I, Abdellaoui M, Tahri H. Conjunctival melanoma and xeroderma pigmentosum, a rare association. Bull Soc Belge Ophtalmol. 2012;319:17–21.

    PubMed  Google Scholar 

  9. Hu DN, Yu G, McCormick SA, et al. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol. 2008;145(3):418–23.

    Article  PubMed  Google Scholar 

  10. Pane AR, Hirst LW. Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia. Ophthalmic Epidemiol. 2000;7(3):159–67.

    PubMed  CAS  Google Scholar 

  11. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol. 1985;16(2):136–43.

    Article  PubMed  CAS  Google Scholar 

  12. Shields CL, Markowitz JS, Belinsky I, et al. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology. 2011;118(2):389–95.

    Article  PubMed  Google Scholar 

  13. Messmer EM, Mackert MJ, Zapp DM, et al. In vivo confocal microscopy of pigmented conjunctival tumors. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1437–45.

    Article  PubMed  Google Scholar 

  14. Ho VH, Prager TC, Diwan H, et al. Ultrasound biomicroscopy for estimation of tumor thickness for conjunctival melanoma. J Clin Ultrasound. 2007;35(9):533–7.

    Article  PubMed  Google Scholar 

  15. Jakobiec FA, Rini FJ, Fraunfelder FT, et al. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology. 1988;95(8):1058–70.

    PubMed  CAS  Google Scholar 

  16. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96(2):147–66.

    PubMed  CAS  Google Scholar 

  17. Folberg R, Jakobiec FA, Bernardino VB, et al. Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology. 1989;96(4):436–61.

    PubMed  CAS  Google Scholar 

  18. Rummelt V, Naumann GO, Folberg R, et al. Surgical management of melanocytoma of the ciliary body with extrascleral extension. Am J Ophthalmol. 1994;117(2):169–76.

    PubMed  CAS  Google Scholar 

  19. Kiratli H, Shields CL, Shields JA, et al. Metastatic tumours to the conjunctiva: report of 10 cases. Br J Ophthalmol. 1996;80(1):5–8.

    Article  PubMed  CAS  Google Scholar 

  20. Heegaard S, Jensen OA, Prause JU. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S-100 protein and HMB-45. Melanoma Res. 2000;19(4):350–4.

    Article  Google Scholar 

  21. Sharara NA, Alexander RA, Luthert PJ, et al. Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology. 2001;39(4):426–31.

    Article  PubMed  CAS  Google Scholar 

  22. Iwamoto S, Burrows RC, Grossniklaus HE, et al. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol. 2002;129(12):1625–9.

    Article  Google Scholar 

  23. Jakobiec FA, Bhat P, Colby KA. Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol. 2010;128(2):174–83.

    Article  PubMed  Google Scholar 

  24. Goldenberg-Cohen N, Cohen Y, Rosenbaum E, et al. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci. 2005;46(9):3027–30.

    Article  PubMed  Google Scholar 

  25. Lake SL, Jmor F, Dopierala J, et al. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci. 2011;52(8):5598–604.

    Article  PubMed  CAS  Google Scholar 

  26. Dratviman-Storobinsky O, Cohen Y, Frenkel S, et al. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51(12):6180–2.

    Article  PubMed  Google Scholar 

  27. Savar A, Esmaeli B, Ho H, et al. Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features. J Cutan Pathol. 2011;38(1):18–24.

    Article  PubMed  Google Scholar 

  28. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol. 2000;118(11):1497–507.

    Article  PubMed  CAS  Google Scholar 

  29. Mudhar HS, Rennie IG. Local conjunctival metastases from primary conjunctival melanoma: clinico-pathological correlation and implications. Br J Ophthalmol. 2013;97(1):33–9.

    Article  PubMed  Google Scholar 

  30. Heindl LM, Hofmann-Rummelt C, Adler W, et al. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology. 2011;118(12):2351–60.

    Article  PubMed  Google Scholar 

  31. Missotten GS, Gambrelle J, de Wolff-Rouendaal D, et al. Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. A series of six patients with nasolacrimal recurrence. Br J Ophthalmol. 2010;94(10):1328–31.

    Article  PubMed  CAS  Google Scholar 

  32. Sandinha T, Russell H, Kemp E, et al. Malignant melanoma of the conjunctiva with intraocular extension: a clinicopathological study of three cases. Graefes Arch Clin Exp Ophthalmol. 2007;245(3):431–6.

    Article  PubMed  Google Scholar 

  33. Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology. 2004;111(4):816–21.

    Article  PubMed  Google Scholar 

  34. Shields JA, Shields CL, DePotter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan lecture. Arch Ophthalmol. 1997;115(6):808–15.

    Article  PubMed  CAS  Google Scholar 

  35. Lommatzsch PK, Lommatzsch RE, Kirsch I, et al. Therapeutic outcome of patients suffering from malignant melanoma of the conjunctiva. Br J Ophthalmol. 1990;74(10):615–9.

    Article  PubMed  CAS  Google Scholar 

  36. Krause L, Ritter C, Wachtlin J, et al. Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma. Klin Monbl Augenheilkd. 2008;225(7):649–52.

    Article  PubMed  CAS  Google Scholar 

  37. Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond). 2009;23(4):801–9.

    Article  CAS  Google Scholar 

  38. Karim R, Conway RM. Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma. Clin Experiment Ophthalmol. 2011;39(4):293–8.

    Article  PubMed  Google Scholar 

  39. Wuestemeyer H, Sauerwein W, Meller D, et al. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(4):438–46.

    Article  PubMed  Google Scholar 

  40. Krause L, Mladenova A, Bechrakis NE, et al. Treatment modalities for conjunctival melanoma. Klin Monbl Augenheilkd. 2009;226(12):1012–6.

    Article  PubMed  CAS  Google Scholar 

  41. Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–14.

    Article  PubMed  CAS  Google Scholar 

  42. Ditta LC, Shildkrot Y, Wilson MW. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. Ophthalmology. 2011;118(9):1754–9.

    Article  PubMed  Google Scholar 

  43. Finger PT, Sedeek RW, Chin KJ. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol. 2008;145(1):124–9.

    Article  PubMed  CAS  Google Scholar 

  44. Herold TR, Hintschich C. Interferon alpha for the treatment of melanocytic conjunctival lesions. Graefes Arch Clin Exp Ophthalmol. 2010;248(1):111–5.

    Article  PubMed  CAS  Google Scholar 

  45. Tatla T, Hungerford J, Plowman N, et al. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease. Laryngoscope. 2005;115(5):817–22.

    Article  PubMed  Google Scholar 

  46. Dalla Pozza G, Ghirlando A, Busato F, et al. Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: a long-term study. Eur J Ophthalmol. 2005;15(4):446–50.

    PubMed  CAS  Google Scholar 

  47. Amato M, Esmaeli B, Ahmadi MA, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph node in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg. 2003;19(2):102–6.

    Article  PubMed  Google Scholar 

  48. Savar A, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology. 2009;116(11):2217–23.

    Article  PubMed  Google Scholar 

  49. Paridaens AD, Minassian DC, McCartney AC, et al. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994;78(4):252–9.

    Article  PubMed  CAS  Google Scholar 

  50. Chapter 50: Malignant melanoma of the conjunctiva. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.p. 539–6.

    Google Scholar 

  51. Yousef YA, Finger PT. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol. 2012;139(5):599–606.

    Google Scholar 

  52. Shields CL, Kaliki S, Al-Dahmash SA, et al. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg. 2012;28(5):313–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacob Pe’er MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pe’er, J., Folberg, R. (2014). Conjunctival and Corneal Tumors: Melanoma. In: Pe'er, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38336-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38336-6_18

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38335-9

  • Online ISBN: 978-3-642-38336-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics